ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:ANGLE Plc (AGL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C9445
◆発行会社(調査会社):GlobalData
◆発行日:2018年11月
◆ページ数:28
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
ANGLE Plc (ANGLE) is a medical diagnostic company that offers cancer diagnostics and foetal health products. The company develops products for use in rare cell diagnostics that enable early, accurate identification of an individual’s condition for the prevention, treatment, and monitoring of disease. Its product Parsortix cell separation system, which captures very rare circulating tumor cells in cancer patient blood. ANGLE’s Parsortix cell separation system uses a microfluidic technology in the form of a one-time use cassette to capture and then harvest circulating tumor cells (CTCs) from blood. The company’s cassette captures CTCs based on their less deformable nature and larger size compared to other blood components. It provides liquid biopsy (blood test) that enables the detection and investigation of mutations in the patient’s cancer for personalized cancer care. The company’s harvested CTCs have a range of applications such as diagnosis, prognosis, mutational analysis and drug selection, drug development, assessment of treatment effectiveness and remission monitoring. It has operations in the US and the UK. ANGLE is headquartered in Guildford, the UK.

ANGLE Plc (AGL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Plc, Pharmaceuticals & Healthcare, Deal Details 11
Asset Purchase 11
ANGLE Acquires Assets from Axela 11
Private Equity 12
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Partnerships 13
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Equity Offering 15
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc – Key Competitors 19
ANGLE Plc – Key Employees 20
ANGLE Plc – Locations And Subsidiaries 21
Head Office 21
Other Locations & Subsidiaries 21
Recent Developments 22
Financial Announcements 22
Jul 25, 2018: ANGLE: Preliminary Results for the year ended 30 April 2018 22
Corporate Communications 26
Nov 01, 2018: Appointment of Dr Jan Groen as non-executive director 26
May 14, 2018: Angle Appoints Leading NHS Prostate Cancer Surgeon As Scientific Advisor 27
Appendix 28
Methodology 28
About GlobalData 28
Contact Us 28
Disclaimer 28

List of Tables
ANGLE Plc, Pharmaceuticals & Healthcare, Key Facts, 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9
ANGLE Plc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
ANGLE Acquires Assets from Axela 11
ANGLE Raises USD2.5 Million in Private Placement of Shares 12
Angle Enters into Co-Development Agreement with Royal Philips 13
Angle Enters into Agreement with MD Anderson Cancer Center 14
Angle Raises USD16.8 Million in Private Placement of Shares 15
ANGLE Raises USD3.7 Million in Private Placement of Shares 17
ANGLE Raises USD13.7 Million in Private Placement of Shares 18
ANGLE Plc, Key Competitors 19
ANGLE Plc, Key Employees 20
ANGLE Plc, Other Locations 21

List of Figures
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
ANGLE Plc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
ANGLE Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
ANGLE Plc, Medical Devices Deals, 2012 to YTD 2018 9

★海外企業調査レポート[ANGLE Plc (AGL):製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Align Technology, Inc. (ALGN)-医療機器分野:企業M&A・提携分析
    Summary Align Technology, Inc. (Align) is a medical device company that designs, manufactures and markets orthodontics and services for orthodontic and restorative dentistry. The company’s portfolio encompasses a system of clear aligner therapy, intra-oral scanners, and computer-aided design, and co …
  • Premera Blue Cross:企業の戦略的SWOT分析
    Premera Blue Cross - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and ser …
  • The Cheesecake Factory Incorporated:企業の戦略・SWOT・財務情報
    The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report Summary The Cheesecake Factory Incorporated - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Paradise Co Ltd
    Paradise Co Ltd - Strategy, SWOT and Corporate Finance Report Summary Paradise Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Cypralis Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Cypralis Ltd (Cypralis), formerly Selcia Pharma Ltd is a drug developer that provides discovery and development of therapeutics targeting peptidyl-prolyl isomerases. The company spans its expertise in the development of medicines for degenerative diseases such as acute tissue injury, liver d …
  • Shanghai Institute of Materia Medica Chinese Academy of Sciences:製薬・医療:M&Aディール及び事業提携情報
    Summary Shanghai Institute of Materia Medica Chinese Academy of Sciences (SIMM) is an educational research institute that provides research and development of traditional Chinese medicine. The institute offers solutions in the areas of drug discovery and drug development. It also offers studies of s …
  • OJSC Rosneft Oil Company:企業の戦略・SWOT・財務分析
    OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report Summary OJSC Rosneft Oil Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis – 2017
    Petro Vista Energy Corp Oil & Gas Exploration and Production Operations and Cost Analysis - 2017 Summary Petro Vista Energy Corp (Petro Vista) is an oil and gas company that offers oil and gas exploration and development services. The company offers acquisition, development, exploration, and product …
  • Smith & Nephew plc:企業のM&A・事業提携・投資動向
    Smith & Nephew plc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Smith & Nephew plc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Celgene Corp (CELG)-製薬・医療分野:企業M&A・提携分析
    Summary Celgene Corp (Celgene) is an integrated global biopharmaceutical company that carries out the research, development, manufacture and marketing of novel therapies to treat cancer and immune-inflammatory related diseases through gene and protein regulation. Its product portfolio includes Vidaz …
  • Adimmune Corp (4142):製薬・医療:M&Aディール及び事業提携情報
    Summary Adimmune Corp (Adimmune) is a biopharmaceutical company that manufactures diagnostics, vaccines, and biological products for various diseases. The corporation’s products include tetanus toxoid adsorbed vaccine, influenza vaccine, Japan encephalitis vaccine, and ah1n1 vaccine. It also provide …
  • Barnes & Noble, Inc.:企業の戦略・SWOT・財務情報
    Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report Summary Barnes & Noble, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • AS Eesti Gaas:企業の戦略的SWOT分析
    AS Eesti Gaas - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services …
  • Richardson Electronics Ltd (RELL):企業の財務・戦略的SWOT分析
    Summary Richardson Electronics Ltd (Richardson Electronics) manufactures electron tube. It offers engineered solutions, power grid and microwave tubes and consumables, displays, flat panel detector solutions and parts for diagnostic imaging equipment, power conversion and RF and microwave components …
  • Biocon Ltd (BIOCON):製薬・医療:M&Aディール及び事業提携情報
    Summary Biocon Ltd (Biocon) is a biopharmaceutical company that focuses on the research and development of therapies for the treatment of chronic conditions like cancer, diabetes and autoimmune. The company produces a wide range of active pharmaceutical ingredients (APIs), branded formulations; and …
  • Fenner PLC (FENR):企業の財務・戦略的SWOT分析
    Summary Fenner PLC (Fenner) a subsidiary of Michelin SCA, is a provider of reinforced polymer technology. The company operates in the areas of advanced engineered products and engineered conveyor solutions. Its product portfolio includes heavyweight conveyor belt, high performance polymer components …
  • Vitrolife AB (VITR):企業の財務・戦略的SWOT分析
    Summary Vitrolife AB (Vitrolife) is a developer, producer and marketer of laboratory products. The company provides products such as Oocyte retrieval needles, sperm processing, culture media, culture oil, additional culture media, micromanipulation solutions, vitrolife labware, micromanipulation pip …
  • Eurofins Scientific SE:企業の戦略・SWOT・財務情報
    Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report Summary Eurofins Scientific SE - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Koch Industries, Inc.:企業の戦略・SWOT・財務分析
    Koch Industries, Inc. - Strategy, SWOT and Corporate Finance Report Summary Koch Industries, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • CaroGen Corp-製薬・医療分野:企業M&A・提携分析
    Summary CaroGen Corp (CaroGen) is a vaccine company that offers platform technology development services. The company develops and commercializes nanoparticle therapeutic vaccines. It utilizes its virus-like vesicle platform technology, a proprietary replication competent to develop nano particle th …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆